Ketamine therapy for cancer
Ketamine therapy can play a valuable role in cancer pain management, particularly in neuropathic pain, refractory pain, and opioid-resistant cases.
Ketamine for cancer acts on NMDA receptors involved in pain signalling and may help by reducing central sensitisation, enhancing the effectiveness of other analgesics, and supporting opioid reduction in selected patients.









